Evidence of high rates of burnout symptoms in a cohort with cluster headache
Headache: The Journal of Head and Face Pain · 2026-11-09
DOI: 10.1111/head.70213 ↗Abstract
Abstract Background Cluster headache is a debilitating primary headache disorder. During active bouts, headache attacks occur daily and can last up to 3 h. Besides the excruciating pain, the disorder can greatly impact a patient's mental health, sleep, and life quality. The reoccurring attacks as well as sleep problems may lead to energy depletion and burnout symptoms, which can limit a person's ability to participate in society to the extent they would like to. Objective Our aim was to investigate the extent of burnout symptoms in a Swedish cluster headache cohort using a cross‐sectional approach. We further wanted to study if burnout symptoms can be linked to disease status—and if sex, lifestyle factors, or any specific clinical characteristics may be linked to change in burnout symptoms. Methods Between January 2024 and September 2025, the Shirom‐Melamed Burnout Questionnaire was sent out via the Research Electronic Data Capture platform to 839 study participants with cluster headache. Global scores from the questionnaire were compared between study participants in active bout and remission. Likewise, the scores were analyzed between participants whose remission period had lasted longer than 5 years (long‐term) compared to less than 5 years (short‐term). Lifestyle and clinical factors were further analyzed in study participants with high Shirom‐Melamed Burnout Questionnaire scores (global score >3.75). Results The total number of individuals included in the analysis was 373/839 (44.5%). Scores above threshold (>3.75) were recorded in 65.9% (58/88) of study participants in an active bout compared to 37.5% (90/240) in the remission group (odds ratio [OR] = 3.22, 95% confidence interval [CI] = 1.93–5.38; p < 0.001). Participants in short‐term remission similarly had a higher percentage of scores above threshold compared to participants in long‐term remission (42.0% [73/174] vs. 22.2% [12/54], OR = 2.53, 95% CI = 1.25–5.14; p = 0.009). Participants with burnout scores above 3.75 were more likely to be females (OR = 3.25, 95% CI = 2.04–5.19; p corrected
EUVIMED